Literature DB >> 19682333

Instituting a thawed plasma procedure: it just makes sense and saves cents.

Gay Wehrli1, Nancy E Taylor, Annette L Haines, Thomas W Brady, Paul D Mintz.   

Abstract

BACKGROUND: The objectives of this time-series study were to elucidate the impact of a thawed plasma standard operating procedure (TP SOP) on plasma wastage and on cost savings. STUDY DESIGN AND METHODS: This study compared plasma wastage for 1 year before versus 1 year after implementation of a TP SOP.
RESULTS: The plasma wastage and discard declined 79.7 and 64.9%, respectively, with a cost savings of $15,654.79 during the 1 year after implementation of the TP SOP. The risk that a unit of plasma would be wasted decreased 86.2% from Year 1 to Year 2 and the risk that a unit of plasma would be discarded decreased 76.3% from Year 1 to Year 2.
CONCLUSION: Our study showed the positive, sustained, impact of implementing a TP SOP. Twelve months after introducing the SOP our Blood Bank and Transfusion Medicine Services' plasma wastage and discard were dramatically reduced, saving thousands of dollars. Initiating a TP SOP just makes sense; it is easy to implement, conserves plasma, and saves cents.

Mesh:

Substances:

Year:  2009        PMID: 19682333     DOI: 10.1111/j.1537-2995.2009.02342.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

1.  Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial.

Authors:  Deborah J Novak; Yu Bai; Rhonda K Cooke; Marisa B Marques; Magali J Fontaine; Jerome L Gottschall; Patricia M Carey; Richard M Scanlan; Eberhard W Fiebig; Ira A Shulman; Janice M Nelson; Sherri Flax; Veda Duncan; Jennifer A Daniel-Johnson; Jeannie L Callum; John B Holcomb; Erin E Fox; Sarah Baraniuk; Barbara C Tilley; Martin A Schreiber; Kenji Inaba; Sandro Rizoli; Jeanette M Podbielski; Bryan A Cotton; John R Hess
Journal:  Transfusion       Date:  2015-03-30       Impact factor: 3.157

2.  Coagulation Factor Activities Changes Over 5 Days in Thawed Fresh Frozen Plasma Stored at Different Initial Storage Temperatures.

Authors:  Siti Salmah Noordin; Faraizah Abdul Karim; Wan Mohd Zahiruddin Bin Wan Mohammad; Abdul Rahim Hussein
Journal:  Indian J Hematol Blood Transfus       Date:  2017-10-07       Impact factor: 0.900

3.  Multicenter observational prehospital resuscitation on helicopter study.

Authors:  John B Holcomb; Michael D Swartz; Stacia M DeSantis; Thomas J Greene; Erin E Fox; Deborah M Stein; Eileen M Bulger; Jeffrey D Kerby; Michael Goodman; Martin A Schreiber; Martin D Zielinski; Terence O'Keeffe; Kenji Inaba; Jeffrey S Tomasek; Jeanette M Podbielski; Savitri N Appana; Misung Yi; Charles E Wade
Journal:  J Trauma Acute Care Surg       Date:  2017-07       Impact factor: 3.313

4.  The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance.

Authors:  R S Bercovitz; M R Kelher; S Y Khan; K J Land; T H Berry; C C Silliman
Journal:  Vox Sang       Date:  2011-11-18       Impact factor: 2.144

5.  Every minute counts: Time to delivery of initial massive transfusion cooler and its impact on mortality.

Authors:  David E Meyer; Laura E Vincent; Erin E Fox; Terence OʼKeeffe; Kenji Inaba; Eileen Bulger; John B Holcomb; Bryan A Cotton
Journal:  J Trauma Acute Care Surg       Date:  2017-07       Impact factor: 3.313

6.  An emergency department thawed plasma protocol for severely injured patients.

Authors:  Zayde A Radwan; Yu Bai; Nena Matijevic; Deborah J del Junco; James J McCarthy; Charles E Wade; John B Holcomb; Bryan A Cotton
Journal:  JAMA Surg       Date:  2013-02       Impact factor: 14.766

7.  14-Day thawed plasma retains clot enhancing properties and inhibits tPA-induced fibrinolysis.

Authors:  Benjamin R Huebner; Ernest E Moore; Hunter B Moore; Raymond Shepherd-Singh; Angela Sauaia; Gregory R Stettler; Geoffrey R Nunns; Christopher C Silliman
Journal:  J Surg Res       Date:  2017-05-12       Impact factor: 2.192

Review 8.  Cryoprecipitate therapy.

Authors:  B Nascimento; L T Goodnough; J H Levy
Journal:  Br J Anaesth       Date:  2014-06-27       Impact factor: 9.166

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.